When: Pullback to $250–$255 with confirmed technical reset

Then: Add remaining 50% of new capital

When: Close above $276.88 on volume ≥7M with MACD bullish re-cross, OR Q3 earnings beat with ex-Stelara bridge ≥9% and constructive FY guide

Then: Re-rate to Hold

REDUCE POSITION 20-30 PERCENT; MAINTAIN 70-80 PERCENT CORE EXPOSURE

• Q2 2026 revenue hit an all-time high at 25.3 billion dollars with 6.6 percent growth re-accelerating; free cash flow surged to 7.3 billion in a single quarter; ROE sits at 25.7 percent
• Forward P/E of 22 times on 41 percent expected earnings growth is not historically expensive for a AAA-rated compounder; normalized EPS guidance at 12.14 dollars makes the PEG ratio of 2.8 an optical trap
• Technical setup is a Bollinger squeeze, not a breakdown: price consolidating between 262 and 277 with ATR at 5.27 dollars; RSI at 53.66 is neutral; hierarchy intact (price above 10 EMA at 268.93 above 50 SMA at 263 above 200 SMA at 237)
• Supports 20-30 percent trim to reduce binary Q3 earnings catalyst exposure, lock in gains at near 52-week highs, preserve 70-80 percent participation if consolidation resolves bullishly, maintain dividend income, and keep dry powder to add back at 263 zone or below
• Opposes 40-50 percent trim as crossing from prudent risk reduction into aggressive de-risking that forfeits asymmetric upside if stock pushes toward 280 or above into year-end
• Defends 280 stop loss as pre-committed structural exit above resistance providing 11 dollars (approximately 2 times ATR) of room, calibrated to avoid noise while protecting against breakout failure
• Macro rotation thesis lacks merit: no defined entry prices, stops, or reinvestment plan for cyclicals; falling recession odds with no rate cuts is a stable environment for high-quality compounders, not a signal to liquidate a 0.235 beta defensive name

→ vs aggressive: The aggressive analyst's 40-50 percent trim recommendation crosses the line from prudent risk reduction into aggressive de-risking that forfeits the asymmetric upside if the technical setup resolves bullishly toward 277-280; a 50 percent trim means giving back half gains while the stock keeps compounding if Bollinger squeeze breaks higher

→ vs aggressive: The aggressive analyst's probability-weighted expected return math is built on assumptions that cannot be accepted: the 35 percent bearish probability appears cherry-picked from the technical report's own distribution showing 55 percent bullish, 35 percent bearish, 10 percent neutral, and the math assumes a single discrete directional bet rather than managing a position with cost basis well below current price

→ vs aggressive: The aggressive analyst's technical deterioration narrative mischaracterizes the setup: RSI at 53.66 is neutral, not bearish; the MACD crossing below signal represents a stock that rallied from low 260s to 278 consolidating in a tight range, not a rolling-over name; RSI heading toward 50 is textbook consolidation behavior, not capitulation

→ vs aggressive: The aggressive analyst's macro rotation thesis lacks operational specificity: selling a 0.235 beta defensive name into unnamed pro-cyclical sectors at unknown valuations without defined entry points or stops constitutes gambling on dual timing rather than risk management; the worst mistake is forcing a sale without a defined reinvestment plan with equal or better risk-adjusted return

Trim 30% tactically into $268-$272 zone; preserve 70% core exposure; add back at $263 if post-earnings reaction is a non-event; stop remaining position at $258; do not initiate new short capital; be prepared to trim another tranche if earnings disappoint on guidance or Stelara erosion.

• Technical deterioration is real but not catastrophic: MACD crossed below signal with expanding negative histogram, RSI at 53.66 and cooling, price below 20-day VWMA
• September 18 redistribution day with 16.4 million shares traded near $270
• Fundamental story intact: Q2 revenue all-time high of $25.3B with 6.6% growth re-accelerating, FCF surging to $7.3B in a single quarter, ROE at 25.7%, AAA credit rating, net leverage under 1x EBITDA, 64-year dividend hike streak
• Forward P/E of 22x with 41% expected EPS growth is not historically demanding for this franchise quality
• 58% TTM move was earned through fundamental delivery; optical valuation trap from depressed 2024 EPS is real
• Binary catalyst: mid-October Q3 earnings is the real inflection point
• Risk-reward genuinely improves at $263 zone
• JJN consolidating near top of range, not leading underperformance; institutional news flow is decisively constructive
• Structural stop at $255 requires giving back roughly 5% from current levels before triggering
• Probability tree: 55 bullish, 35 bearish, 10 neutral—this is coin-flip with slight upside bias, not strong confidence
• Defensive premium is probably capped at current levels but isn't actively collapsing—trim but don't liquidate

→ vs aggressive: Macro rotation thesis is a forward-looking prediction, not an observed fact; institutional news flow is decisively constructive with JNJ being explicitly named as crash-protection holding, not a rotation candidate

→ vs aggressive: 35 percent bearish probability is a coarse judgment from a single technical report, not a hard estimate; expected return must account for dividend carry, time value, and that this is managing an existing position with cost basis well below current price

→ vs conservative: Bollinger squeeze is a coiled spring that can release in either direction; RSI at 53.66 and cooling is not a neutral data point when aligned with other deterioration signals

→ vs conservative: 200 SMA intact at 237 does not prevent trading through 263 and 262 first on the way there; structural stop at 255 absorbs downside drawdown before firing

→ vs conservative: The argument that the aggressive analyst hasn't identified where capital goes is a deflection—trim sizing should be driven by the position's own risk profile, not by the next trade